
Leucosceptoside A
CAS No. 83529-62-8
Leucosceptoside A( —— )
Catalog No. M31560 CAS No. 83529-62-8
Leucosceptoside A shows inhibitory activity against PKCalpha with the IC50 value of 19.0 microM; it also exhibits strong inhibitory capacity against α-glucosidase.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 286 | In Stock |
![]() ![]() |
50MG | Get Quote | In Stock |
![]() ![]() |
100MG | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameLeucosceptoside A
-
NoteResearch use only, not for human use.
-
Brief DescriptionLeucosceptoside A shows inhibitory activity against PKCalpha with the IC50 value of 19.0 microM; it also exhibits strong inhibitory capacity against α-glucosidase.
-
DescriptionLeucosceptoside A shows inhibitory activity against PKCalpha with the IC50 value of 19.0 microM; it also exhibits strong inhibitory capacity against α-glucosidase. Leucosceptoside A has antihypertensive effect, it shows angiotensin converting enzyme (ACE) inhibitory effect in a dose-dependent manner of which IC(50) value of 423+/-18.8 microg/ml.
-
In VitroLeucosceptoside A shows weak angiotensin converting enzyme (ACE) inhibitory effect.Leucosceptoside A (4-16 μM) significantly reduces 1-methyl-4-phenylpyridinium ion (MPP+)-induced death of mesencephalic neurons.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number83529-62-8
-
Formula Weight638.61
-
Molecular FormulaC30H38O15
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
Cotoin
Cotoin is a natural product isolated from the stem bark of Garcinia virgate.Cotoin has antispasmodic activity and reduces the tone and contraction of isolated rabbit intestine.
-
Platycoside E
Platycoside E?is a platycodigenin-type saponin isolated from the root of Platycodon grandiflorum with haemolytic activity and adjuvant potential.
-
Lascufloxacin
Lascufloxacin has the potential for various infectious diseases treatment, including lower respiratory tract infections.